Ligand Pharmaceuticals Inc (LGND)
SG&A Expense Growth
17.54%
Fiscal year · Period ending:
LGND SG&A Expense Growth
Latest reported17.54%period ending
Latest reported17.54%period ending
LGND FY SG&A Growth (YoY) (0.00% → 17.54%)
Latest values, visible window
High-resolution chart · PNG
LGND sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 17.5388% | |
| 48.9941% | |
| -24.6525% | |
| 49.7371% | |
| -22.0323% | |
| 43.2814% | |
| 10.998% | |
| 31.693% | |
| 7.6331% | |
| 9.2009% | |
| 8.0106% | |
| 25.5004% | |
| 11.6464% | |
| 7.5516% | |
| -49.6114% | |
| 95.4046% | |
| -36.0479% | |
| -21.7856% | |
| -87.7518% | |
| 131.6983% | |
| 11.7674% | |
| 57.118% | |
| 46.4106% | |
| 21.062% | |
| 0.9175% | |
| 24.9597% | |
| 64.4578% | |
| 64.3564% | |
| -0.9804% | |
| 27.5% | |
| 14.2857% | |
| 0% |